Metronomic therapy for malignant peripheral nerve sheath tumor in neurofibromatosis type 1

被引:5
作者
Chaudhary, Narendra [1 ]
Borker, Anupama [1 ]
机构
[1] Kasturba Med Coll & Hosp, Dept Pediat, Pediat Hematol Oncol Unit, Manipal 576104, Karnataka, India
关键词
malignant peripheral nerve sheath tumor; metronomic chemotherapy; neurofibromatosis type-1; GROWTH-FACTOR RECEPTOR; PLEXIFORM NEUROFIBROMA; CHEMOTHERAPY; ANGIOGENESIS; RECURRENT; CHILDREN;
D O I
10.1002/pbc.24245
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor especially in the patients with neurofibromatosis type 1 (NF1). Without a complete surgical excision, prognosis is guarded. We describe a 10-year-old male with NF1 with MPNST, who had a local relapse within 5 weeks of surgical excision. Chemoradiotherapy did not result in tumor regression. Initiation of palliative oral metronomic therapy resulted in complete remission after six cycles. The patient continues to be in remission, 20 months after completion of nine cycles of metronomic therapy. Metronomic therapy may be effective in MPNST where conventional chemotherapy and radiotherapy fails. Pediatr Blood Cancer 2012; 59: 13171319. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1317 / 1319
页数:3
相关论文
共 13 条
[1]  
Angelov L, 1999, CANCER RES, V59, P5536
[2]   Management of childhood malignant peripheral nerve sheath tumor [J].
Ferrari A. ;
Bisogno G. ;
Carli M. .
Pediatric Drugs, 2007, 9 (4) :239-248
[3]   Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groups [J].
Ferrari, Andrea ;
Miceli, Rosalba ;
Rey, Annie ;
Oberlin, Odile ;
Orbach, Daniel ;
Brennan, Bernadette ;
Mariani, Luigi ;
Carli, Modesto ;
Bisogno, Gianni ;
Cecchetto, Giovanni ;
De Salvo, Gian Luca ;
Casanova, Michela ;
Vannoesel, Max M. ;
Kelsey, Anna ;
Stevens, Michael C. ;
Devidas, Meenakshi ;
Pappo, Alberto S. ;
Spunt, Sheri L. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (05) :724-731
[4]   Children Treated With Metronomic Chemotherapy in a Low-income Country: METRO-MALI-01 [J].
Fousseyni, Traore ;
Diawara, Maimouna ;
Pasquier, Eddy ;
Andre, Nicolas .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (01) :31-34
[5]  
Friedrich RE, 2007, ANTICANCER RES, V27, P2085
[6]   The Role of Angiogenesis in the Transformation of Plexiform Neurofibroma into Malignant Peripheral Nerve Sheath Tumors in Children With Neurofibromatosis Type 1 [J].
Gesundheit, Benjamin ;
Parkin, Patricia ;
Greenberg, Mark ;
Baruchel, Sylvain ;
Senger, Christof ;
Kapelushnik, Josef ;
Smith, Charles ;
Klement, Giannoula Lakka .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (07) :548-553
[7]   Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1 [J].
Gupta, A ;
Cohen, BH ;
Ruggieri, P ;
Packer, RJ ;
Phillips, PC .
NEUROLOGY, 2003, 60 (01) :130-132
[8]   A feasibility trial of antiangiogenic (Metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer [J].
Kieran, MW ;
Turner, CD ;
Rubin, JB ;
Chi, SX ;
Zimmerman, MA ;
Chordas, C ;
Klement, G ;
Laforme, A ;
Gordon, A ;
Thomas, A ;
Neuberg, D ;
Browder, T ;
Folkman, J .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (11) :573-581
[9]   First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study [J].
Kroep, J. R. ;
Ouali, M. ;
Gelderblom, H. ;
Le Cesne, A. ;
Dekker, T. J. A. ;
Van Glabbeke, M. ;
Hogendoorn, P. C. W. ;
Hohenberger, P. .
ANNALS OF ONCOLOGY, 2011, 22 (01) :207-214
[10]   Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis [J].
Ling, BC ;
Wu, JQ ;
Miller, SJ ;
Monk, KR ;
Shamekh, R ;
Rizvi, TA ;
DeCourten-Myers, G ;
Vogel, KS ;
DeClue, JE ;
Ratner, N .
CANCER CELL, 2005, 7 (01) :65-75